PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Allarity Therapeutics, Inc.
Filed: January 26, 2024
Period of Report: January 26, 2024
Accession Number: 0001213900-24-007041

View Document ↗ View on SEC.gov ↗